Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGEN-IHD: G-CSF and Bone Marrow Cells in Ischaemic Heart Failure
NCT00747708Phase 3Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Aug 2005
- Primary completion
- May 2012
- Modality
- Cytokines & Interferons, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of granulocyte colony-stimulating factor, autologous bone marrow-derived mononuclear cell in heart failure (HF), sponsored by Barts Health NHS Trust. Started Aug 2005; status: completed.
02
Drugs
granulocyte colony-stimulating factorautologous bone marrow-derived mononuclear cell
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00747708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747708.